http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2439057-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf03672ef18280dca3bdeae0441388de
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08
filingDate 2006-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c46902aab0d4b34fae52ce3bff1692e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db0cddab4fb21c0e514b20d1b110eac8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ed327658d516cccc1ab39a1eb4cf0c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_206cf1bcfc99b23b06a3d90be60ae836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd9106e9799287be2bfc3e8bb1a59796
publicationDate 2012-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2439057-C2
titleOfInvention Method of obtaining antiemetic medication
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: claimed invention relates to method of obtaining optically pure antiemetic medication, R-(+)-ondansetron, which includes the following stages: a) processing of ondansetron hydrochloride with base, which is selected from group, containing metal hydroxide and carbonate or bicarbonate; b) processing of free ondansetron base with R/S-(+)-n-toluyl tartrate acid in mixture of dimethylforamide and water obtaining salt of 3-R/S-ondansetron-n-toluene tartrate acid; c) fractional recrystallisation of salt of 3-R/S- ondansetron-n-di-toluene tartrate acid from mixture of dimethylformamide and water, if necessary, in presence of primer obtaining salt of 3-R-(+)- ondansetron-n-di-toluene tartrate acid of required enantiomer purity; and processing by base with obtaining free base of 3-R-(+)- ondansetron, and at first ondansetron salt is dissolved in water at room temperatute, after which dimethylformamide is added to solution, with further heating of mixture to 80-85°C, cooling to 60°C and filtration at that temperature, ratio of water and dimethylformamide volume in mixture constituting 2:1; d) processing of free base of R-(+)-ondansetron with hydrochloric acid in presence of alcohol as solvent obtaining 3-R-(+)-ondansetron hydrochloride. n EFFECT: claimed method is less time-consuming and ensures higher product purity in comparison with known methods-analogues. n 4 cl, 9 ex
priorityDate 2006-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416055646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449851370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID667538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57501259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426517444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16212279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21899424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407832258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11391247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450882500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57467826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426222914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13001166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13318575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451280090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420663404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410571003

Total number of triples: 62.